The FDA has suggested an Indian API maker hire a consultant that understands FDA regulations after finding the company didn’t have a grasp of some basic requirements, including how to make sure the ...

The FDA has banned products from a Chinese API maker and suggested it get a consultant to direct upgrades after an inspection found serious problems in its manufacturing processes, some of which had ...

In its third exit from an Indian portfolio company within a month, Asia focused hedge fund Steadview Capital has sold more stake in a publicly listed active pharmaceutical ingredients (API) maker.

Mumbai, Oct 12 () Private equity fund PAG is picking up a controlling stake in active pharmaceutical ingredient (API) maker Anjan Drug for over USD 70 million, sources said on Monday. Mumbai, Oct 12 ( ...

Piramal Pharma Solutions (PPS), the contract development and manufacturing organisation of Piramal Pharma Ltd on Wednesday announced that it has entered into an agreement to acquire 100 per cent stake ...

Ahmedabad-based drugmaker Corona Remedies Pvt Ltd has picked up a minority stake in hormone API maker La Chandra Pharmalab Pvt Ltd as a part of a strategic collaboration between the two companies. La ...

A US state pension fund has invested in a Hyderabad-based active pharmaceutical ingredients (API) maker. This is the latest in a string of deals by investors in the Indian bulk drugs space as pharma ...